Ostarine is a selective androgen receptor modulator that is sometimes known as Enobosarm, GTx-024, or MK-2866. Its scientific name is (2S-3-(4-cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide.
The Make-up of Ostarine
Like other selective androgen receptor modulators, Ostarine is considered to be a ligand. What this means is, it is a small molecule that forms a complex biomolecule in order to serve a specifically targeted biological purpose. On an even more intimate level, it is a molecule that triggers a signal, binding to a specific site on a target protein. According to scientific study based on animal test subjects, Ostarine has been shown to target the receptors that are responsible for the osteo (that is, bone) and myo (that is, muscular) anabolic activity. Once the peptide links up with the receptor, it causes an advanced expression of genes and an increase in protein synthesis. This, in turn, causes an increase in the rate in which muscular and skeletal tissue is built.
Scientific research on male animal test subjects have also determined that the peptide solely focuses on the receptors that are responsible for protein synthesis as it relates to muscle growth, and does not produce any residual growth effects on the prostate gland or any other secondary sexual organs as controlled by the subjects’ endocrine system.
Ostarine and Muscular Atrophy
Because of Ostarine’s ability to specifically hone in on cellular receptors that express proteins related to the growth of muscular and skeletal tissue, scientific study on animal test subjects have been primarily built on its effectiveness in relation to the disease known as muscle atrophy.
Muscle atrophy, which is sometimes known as muscle wasting, is a degenerative disease that is characterized by an involuntary decrease in muscle mass. It is a disease that is oftentimes a secondary issue that is caused by an serious overarching primary disease, such as:
- Liver failure
- Congestive heart failure
- Certain types of cancers
Muscle atrophy can also manifest itself in smaller, less life-threatening conditions, such as when a cast is put on a limb or extended bedrest. Because muscular atrophy is marked by a break down in muscular tissue, the condition is tied to extreme muscle weakness. While this is the most prominent manifestation of the disease, it is also marked by different characteristics, such as fatigue and a severe, involuntary loss of appetite. Additionally, it is also has a tendency to manifest itself as a natural part of the advanced aging process.
Scientific research on animal test subjects has determined that because of Ostarine’s capability to specifically target the type of androgen receptors that cause an elevated expression of the secretions responsible for muscle mass growth, the peptide is thought to be able to counteract the effects of muscular atrophy by replacing and restoring the muscular and skeletal tissue that may be lost in an atrophy episode.
Osterine, Osteoporosis, and Bone Density Issues
Because scientific study on animal test subjects has determined that Osterine has a specific affinity to bind to cellular receptors responsible for the proliferation of secretions related to bone growth, it is theorized that the peptide could contain properties that would enable it to stem the effect of the progressive bone disease known as osteoporosis. The theory here is that the peptide would generate a greater amount of secretions to enable a quicker restoration for the deteriorating bone density that is osteoporosis’s hallmark. This in turn would give a female animal test subject a better opportunity to maintain homeostasis within their bone structure.
Scientific research on animal test subject has also led to the theory that the peptide could be beneficial in various therapeutically aspects. For example, it is theorized that the peptide could be used in conjunction with other concurrent treatments that may cause a residual reduction in bone mineral density as a secondary side effect. Another theoretical benefit relating to Osterine’s bone growth capabilities is that it could have a positive application in rehabbing specific bone or tendon related injuries, such as torn ligaments or bone fractures.
Chemical Validity and Research
It should be noted that while the functionality of Ostarine has been determined, its exact chemical structure is still under wraps. Any information that is shown to link the peptide with the chemical structure of [S-4], or andarine, should not be viewed as official data concerning the peptide.
Additionally, it should also be noted that Ostarine and its scientific study on animal test subjects is still in the research phase. Any use related to its research should be strictly confined to a strictly controlled environment of study, such as a laboratory or medical research facility.